Analytical Impact of the Transport of Pathological Biological Material by Drone (PATH-AIRCHU)

Verification of the Absence of Analytical Impact of the Transport of Pathological Biological Material by Drone Within the Amiens-Picardie University Hospital

The Hospital Group of Territory Somme Littoral Sud, through its biology sector and in partnership with the company DELIVRONE, aims to engage in the experiment of transporting biological samples by means of a drone platform. Transport by air will be between the CHAM, the Abbeville Hospital and the CHU Amiens-Picardie by flying as much as possible over the waterways via the Somme. With a flight speed of around 100km/h at an altitude between 80 and 120 m, drones will be able to connect sites in less than an hour by transporting packages between 2 and 3 kg. Powered by propellers connected to rechargeable batteries, these drones do not emit CO2. This type of transport has not been validated in France by measuring the analytical impact of transport constraints for medical biology, and has never been evaluated according to the criteria of ISO 15189 standard allowing the certification of medical biology laboratories. Validation steps of this transportation method are therefore necessary on pathological samples prior to routine use. The aim of the project is to verify the absence of analytical impact of the transport of pathological biological samples by drone under defined flight conditions, according to the ISO15189 norm.

Study Overview

• Status: Withdrawn
• Conditions: Biological Samples
• Intervention / Treatment: Other: drone transport

• Study Type: Observational

Contacts and Locations

Study Locations

• France
  • Picardie
    • Amiens, Picardie, France, 80054
      • CHU Amiens Picardie

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

If eligible for the study, patients from the central blood collection unit and the day hospitals of the CHU Amiens-Picardie will be offered to participate in the study. After information and consent of the patient, blood sampling will be performed to obtain the samples necessary for the normal medical management of the patient, as well as additional tubes corresponding to the same prescribed analyses. The collection of the extra tubes will therefore be done at the same time as the routine collection, without any additional invasive procedure.

Description

Inclusion Criteria:

• Patients admitted to the Amiens-Picardie University Hospital and having benefited from medical biology examinations including the parameters of interest
• according to the usual management modalities and without additional sampling
• at the time of the test period

Exclusion Criteria:

• Refusal to participate in the study

Study Plan

How is the study designed?

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
no intervention
drone transportation	Other: drone transport; additional transport of samples at room temperature by drone (departure from the CHU Amiens-Picardie, 1 hour flight in the CHU Amiens-Picardie air perimeter, return to the CHU Amiens-Picardie)

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
variation of ASAT concentration between both groups	one day
variation of ALAT concentration between both groups	one day
variation of BNP concentration between both groups	one day
variation of LDH concentration between both groups	one day
variation of Glucose concentration between both groups	one day
variation of Troponin concentration between both groups	one day
variation of Potassium concentration between both groups	one day
variation of HIL concentration between both groups	one day

Collaborators and Investigators

• Sponsor: Centre Hospitalier Universitaire, Amiens

Study record dates

Study Major Dates

• Study Start (Actual): May 22, 2023
• Primary Completion (Estimated): September 1, 2023
• Study Completion (Estimated): September 1, 2023

Study Registration Dates

• First Submitted: May 24, 2023
• First Submitted That Met QC Criteria: May 24, 2023
• First Posted (Actual): June 2, 2023

Study Record Updates

• Last Update Posted (Estimated): October 6, 2025
• Last Update Submitted That Met QC Criteria: September 30, 2025
• Last Verified: September 1, 2025

More Information

Terms related to this study

• Keywords: biological samples; drone transport; unmanned aerial system; UAS
• Other Study ID Numbers: PI2023_843_0030

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No